- Home
- CLLS vs IPFX Comparison
CLLS vs IPFX Comparison
Compare CLLS & IPFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.25
Company Overview
Basic Information| Metric | CLLS | IPFX |
|---|---|---|
| Founded | 1999 | 2025 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 339.0M |
| IPO Year | 2014 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CLLS | IPFX |
|---|---|---|
| Price | $1.25 | $10.03 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 191.3K | 54.7K |
| Earning Date | 11-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $10.01 |
| 52 Week High | $5.48 | $10.64 |
Technical Indicators
Market Signals| Indicator | CLLS | IPFX |
|---|---|---|
| Relative Strength Index (RSI) | 21.90 | 44.09 |
| Support Level | $1.25 | $10.03 |
| Resistance Level | $2.99 | $10.40 |
| Average True Range (ATR) | 0.08 | 0.01 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 7.63 | 57.14 |
Price Performance
Historical Comparison CLLS
IPFX
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About IPFX Inflection Point Acquisition Corp. VI Class A Ordinary Shares
Inflection Point Acquisition Corp VI is a special purpose acquisition company.